← Leaderboards
Daniel S Ory
Washington University
$14,176,962
Attributed
$17,909,888
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$17,909,888 · 13
By mechanism
R01$11,494,854 · 5
U01$2,255,981 · 2
P50$1,902,254 · 1
P30$1,777,065 · 2
K02$473,850 · 1
P41$5,884 · 2
Top collaborators
- Frederick R. Maxfield9 shared
- Jean E Schaffer8 shared
- Steven Upshaw Walkley6 shared
- Xuntian Jiang2 shared
Most similar at Washington University
Same institution · by research overlap
- Jean E Schaffer$33,853,860
- Jennifer A Philips$15,162,669
- William Todd Cade$2,772,504
- Xuntian Jiang$2,199,946
Others in their field
Top investigators on “Cholesterol”
- Leon J Thal · University Of California San Diego$54,467,813
- Daniel James Rader · University Of Pennsylvania$44,733,174
- Alan Richard Tall · Columbia University Health Sciences$38,760,184
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$38,718,698
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$34,107,220
- Stanley L Hazen · Cleveland Clinic Foundation$28,886,562
Research focus
CholesterolLipidsPathway InteractionsEndoplasmic ReticulumResponseBaseMolecularPhenotypeAffectSterolsLipoproteinsLaboratoriesGene ExpressionAtherosclerosisMetabolismPlasmaResearch PersonnelMonitorMutantRegulationUniversitiesClinical TrialsWashingtonCells
Grant awards (60)
Metabolomics$228,750
P30 · FY2022 · DK · contact PI
Metabolomics$228,750
P30 · FY2021 · DK · contact PI
Metabolomics$228,750
P30 · FY2020 · DK · contact PI
Biomolecular Analysis Core (BMAC)$126,663
P30 · FY2020 · DK · contact PI
Metabolomics$228,750
P30 · FY2019 · DK · contact PI
Biomolecular Analysis Core (BMAC)$126,663
P30 · FY2019 · DK · contact PI
Intravenous delivery of 2-hydroxypropyl-Beta-cyclodextrin for treatment of Niemann-Pick C disease$519,342
U01 · FY2018 · HD · contact PI
Post-lysosomal cholesterol trafficking networks$500,340
R01 · FY2018 · HL · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$494,590
R01 · FY2018 · NS · contact PI
Metabolomics$228,750
P30 · FY2018 · DK · contact PI
Biomolecular Analysis Core (BMAC)$126,663
P30 · FY2018 · DK · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$93,800
R01 · FY2018 · NS · contact PI
Intravenous delivery of 2-hydroxypropyl-Beta-cyclodextrin for treatment of Niemann-Pick C disease$529,267
U01 · FY2017 · HD · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$494,590
R01 · FY2017 · NS · contact PI
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE$266,000
R01 · FY2017 · NS · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$159,938
R01 · FY2017 · NS · contact PI
Biomolecular Analysis Core (BMAC)$126,663
P30 · FY2017 · DK · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$494,590
R01 · FY2016 · NS · contact PI
A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease$381,171
U01 · FY2016 · HD · contact PI
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE$266,000
R01 · FY2016 · NS · contact PI
Biomolecular Analysis Core (BMAC)$126,663
P30 · FY2016 · DK · contact PI
Histone Deacetylase Inhibitors for Treatment of Niemann-Pick C1 Disease$533,965
R01 · FY2015 · NS · contact PI
A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease$465,978
U01 · FY2015 · HD · contact PI
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL$374,300
R01 · FY2015 · HL · contact PI
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE$266,000
R01 · FY2015 · NS · contact PI
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL$372,400
R01 · FY2014 · HL · contact PI
A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease$360,223
U01 · FY2014 · HD · contact PI
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE$263,340
R01 · FY2014 · NS · contact PI
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL$361,760
R01 · FY2013 · HL · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$358,142
R01 · FY2013 · HL · contact PI
OXYSTEROL BIOMARKERS FOR NIEMANN-PICK C DISEASE$266,000
R01 · FY2013 · NS · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$452,200
R01 · FY2012 · HL · contact PI
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL$380,000
R01 · FY2012 · HL · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$432,286
R01 · FY2011 · HL · contact PI
MECHANISM OF OXYSTEROL ACTIVATION OF MEMBRANE CHOLESTEROL$380,000
R01 · FY2011 · HL · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$167,200
R01 · FY2011 · HL · contact PI
LIPID BIOMARKERS FOR DIABETIC COMPLICATIONS$546,511
R01 · FY2010 · HL · contact PI
Oxysterols, Atherosclerosis and Metabolic Syndrome$391,466
P50 · FY2010 · HL · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$380,000
R01 · FY2010 · HL · contact PI
REGULATION OF CHOLESTEROL HOMEOSTASIS BY NONCODING RNAS$53,200
R01 · FY2010 · HL · contact PI
LIPID BIOMARKERS FOR DIABETIC COMPLICATIONS$573,276
R01 · FY2009 · HL · contact PI
Oxysterols, Atherosclerosis and Metabolic Syndrome$388,488
P50 · FY2009 · HL · contact PI
Mechanism of Endocytic Trafficking of Cholesterol$332,082
R01 · FY2009 · HL · contact PI
Oxysterols, Atherosclerosis and Metabolic Syndrome$373,782
P50 · FY2008 · HL · contact PI
Mechanism of Endocytic Trafficking of Cholesterol$332,082
R01 · FY2008 · HL · contact PI
Oxysterols, Atherosclerosis and Metabolic Syndrome$379,890
P50 · FY2007 · HL · contact PI
Mechanism of Endocytic Trafficking of Cholesterol$332,355
R01 · FY2007 · HL · contact PI
Oxysterols, Atherosclerosis and Metabolic Syndrome$368,628
P50 · FY2006 · HL · contact PI
Mechanism of Endocytic Trafficking of Cholesterol$343,407
R01 · FY2006 · HL · contact PI
THE NIEMANN-PICK DISEASE GENES REGULATORS OF CELLULAR CHOLESTEROL HOMEOSTASIS$2,942
P41 · FY2006 · RR · contact PI
NUCLEAR RECEPTOR SIGNALING IN THE CONTROL OF CHOLESTEROL HOMEOSTASIS$2,942
P41 · FY2006 · RR · contact PI
Mechanism of Endocytic Trafficking of Cholesterol$306,000
R01 · FY2005 · HL
MOLECULAR MECHANISM OF CELLULAR CHOLESTEROL TRAFFICKING$94,770
K02 · FY2005 · HL
Mechanism of Endocytic Trafficking of Cholesterol$306,000
R01 · FY2004 · HL
MOLECULAR MECHANISM OF CELLULAR CHOLESTEROL TRAFFICKING$94,770
K02 · FY2004 · HL
Mechanism of Endocytic Trafficking of Cholesterol$306,000
R01 · FY2003 · HL
MOLECULAR MECHANISM OF CELLULAR CHOLESTEROL TRAFFICKING$94,770
K02 · FY2003 · HL
Mechanism of Endocytic Trafficking of Cholesterol$306,500
R01 · FY2002 · HL
MOLECULAR MECHANISM OF CELLULAR CHOLESTEROL TRAFFICKING$94,770
K02 · FY2002 · HL
MOLECULAR MECHANISM OF CELLULAR CHOLESTEROL TRAFFICKING$94,770
K02 · FY2001 · HL